From-kin-(“interleukin”) +-umab(“human monoclonal antibody”).
(Thisetymology is missing or incomplete. Please add to it, or discuss it at theEtymology scriptorium.)
ustekinumab (uncountable)
- (pharmacology) Ahumanmonoclonal antibody directed againstinterleukin 12 and interleukin 23, in clinical trials formultiple sclerosis,psoriasis, andpsoriaticarthritis.
2015 December 4, “Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients”, inPLOS ONE[1],→DOI:As another interleukin 12/23 antagonist, briakinumab, was withdrawn from further development in part due to concerns about cardiovascular safety, discussion has also emerged on cardiovascular safety ofustekinumab.
